PAGYLATED INTERFERON AGAINST VIRAL INFECTION Russian patent published in 2007 - IPC A61K47/48 A61K38/19 A61P31/12 

Abstract RU 2311930 C2

FIELD: medicine, in particular new PAGylated interferon against viral infection.

SUBSTANCE: invention relates to PAGylated interferon of formula CH3OCH2CH2(OCH2CH2)2-O-SO2CH2-protein, wherein protein represents interferon, and average molecular mass of polyethylene glycol units is 13000-17000 Da. Also disclosed are pharmaceutical composition containing PAGylated interferon of present invention and pharmaceutically acceptable carrier, and method for controlling of vital infection by administering of PAGylated interferon of present invention in effective amount.

EFFECT: new PAGylated interferon against viral infection.

6 cl, 1 tbl, 6 ex, 1 dwg

Similar patents RU2311930C2

Title Year Author Number
CONJUGATES OF PROTEIN AND POLYETHYLENE GLYCOL DERIVATIVE, PHARMACEUTICAL COMPOSITION, METHOD FOR CONTROL OF VIRAL INFECTION 2004
  • Kurochkin Sergej Nikolaevich
  • Parkanskij Anton Aleksandrovich
  • Chibiljaev Timur Khajdarovich
RU2298560C2
INTERFERON CONJUGATES AND METHOD FOR PRODUCTION THEREOF 2011
  • Nekrasov Arkadij Vasil'Evich
  • Skrypin Vasilij Ivanovich
  • Puchkova Natal'Ja Grigor'Evna
  • Medvedev Sergej Alekseevich
RU2466138C1
MEDICINAL AGENT BASED ON MODIFIED ALPHA INTERFERON WITH PROLONGED THERAPEUTIC ACTION 2008
  • Kurochkin Sergej Nikolaevich
  • Storozhuk Ivan Pavlovich
  • Skrypin Vasilij Ivanovich
RU2382048C1
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON 2010
  • Chernovskaja Tat'Jana Veniaminovna
  • Denisov Lev Aleksandrovich
  • Morozov Dmitrij Valentinovich
  • Rudenko Elena Georgievna
  • Klenova Angelina Vsevolodovna
RU2447083C1
PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON 2013
  • Chernovskaja Tat'Jana Veniaminovna
  • Efanov Jurij Georgievich
  • Morozov Dmitrij Valentinovich
  • Rudenko Elena Georgievna
  • Korzhavin Dmitrij Valer'Evich
  • Ustjugov Jakov Jur'Evich
  • Ivanov Roman Alekseevich
RU2576372C2
METHOD OF SYNTHESISING CONJUGATES OF GLYCOSEAMINOGLYCANES (GAG) WITH BIOLOGICALLY ACTIVE MOLECULES, POLYMER CONJUGATES AND THEIR RESPECTIVE APPLICATIONS 2010
  • D'Ehste Matteo
  • Ren'Er Davide
  • Pazut Dzhanfranko
  • Rozato Antonio
RU2530649C2
PEGYLATED RECOMBINANT CONSENSUS INTERFERON VERSION CONJUGATE AND PREPARATION METHOD AND USE THEREOF 2011
  • Fan Kai
  • Luo Hua
  • Zhang Jilan
  • Li Xiang
  • Zhang Yi
RU2575796C9
PEG DENDRIMER WITH FOUR BRANCHES FOR CONJUGATION WITH PROTEINS AND PEPTIDES 2006
  • Ramon Ehrnandes Khose Ankhel
  • Kastro Odio Fidel' Raul'
  • Saes Martines Vivian Marija
  • Paes Mejreles Rolando
  • Fernandes Sanches Ehduardo
RU2409389C2
HCV-ACTIVE 4'-ASIDONUCLEOSIDES 2011
  • Ma Khan
  • Sarma Keshab
  • Smit Dehvid Bernard
RU2556991C2
USING TYPE III PEGYLATED INTERFERONS FOR TREATING HEPATITIS C 2009
  • Khosman Diana F.
  • Dodds Majkl G.
RU2496514C2

RU 2 311 930 C2

Authors

Kurochkin Sergej Nikolaevich

Parkanskij Anton Aleksandrovich

Chibiljaev Timur Khajdarovich

Dates

2007-12-10Published

2004-04-30Filed